Worth reading
19Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Who is moving to which position
Incoming appointee
1 itemScheduled Appointment Date1 October 2026
Imai Mariko (今井 真理子)
Previous positionHead of the Strategic Alliance Office, concurrently Senior General Manager of the Corporate Planning Department
New positionDeputy Head of the Planning and Administration Division (Corporate Strategy), concurrently Head of the Strategic Alliance Office
Details of organizational changes
The CMC Research Institute will be placed under the jurisdiction of the Pharmaceutical Development Division instead of the Research Division.
| Item | Details |
|---|---|
| Scheduled Appointment Date | 1 October 2026 |
| Name of appointee | Imai Mariko (今井 真理子) |
| Appointee's new position | Deputy Head of the Planning and Administration Division (Corporate Strategy), concurrently Head of the Strategic Alliance Office |
| Appointee's previous position | Head of the Strategic Alliance Office, concurrently Senior General Manager of the Corporate Planning Department |
| Details of organizational changes | The CMC Research Institute will be placed under the jurisdiction of the Pharmaceutical Development Division instead of the Research Division. |
Items this document does not state (16)
Resolution dateDate of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The change in jurisdiction over the CMC Research Institute is intended to "improve operational efficiency." No specific reason is given for the personnel change involving Imai Mariko (今井真理子).
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.